Dyskeratosis Congenita - 9 Studies Found

Active, not recruiting : SCT for Dyskeratosis Congenita or SAA
:
  • Dyskeratosis Congenita
  • Aplastic Anemia

: 2007-03-30
:
  • Drug: Campath 1H 10, 9, 8, 7,

Recruiting : Hematopoietic Stem Cell Transplant for Dyskeratosis Congenita or Severe Aplastic Anemia
:
  • Dyskeratosis Congenita
  • Aplastic Anemia

: 2014-06-10
:
  • Drug: Alemtuzumab Alemtuzumab

Recruiting : Radiation- and Alkylator-free Bone Marrow Transplantation Regimen for Patients With Dyskeratosis Congenita
:
  • Dyskeratosis Congenita
  • Hoyeraal Hreidarss
    : 2012-08-06
    :
    • Biological: alemtuzumab Condit
Completed : Phase II Pilot Study of Granulocyte Colony-Stimulating Factor for Inherited Bone Marrow Failure Syndromes
:
  • Shwachman Syndrome
  • Fanconi's Anemia

  • : 2000-02-24
    : Drug: filgrastim
Completed : Assessing Immune Function in Young Patients With Cytopenia That Did Not Respond to Treatment
:
  • Dyskeratosis Congenita
  • Fanconi Anemia
  • Genetic: polymerase chain reaction
  • Other:

Recruiting : Investigation of the Genetics of Hematologic Diseases
:
  • Bone Marrow Failure Syndromes
  • Erythrocyte Disorder
  • Leukocy
    : 2016-03-16
Recruiting : Cancer in Inherited Bone Marrow Failure Syndromes
:
  • Aplastic Anemia
  • Head and Neck Neoplasms
  • Bone Marrow Failur
    : 2001-11-29
Recruiting : Safety Study of Gene Modified Donor T Cell Infusion After Stem Cell Transplant for Non-Malignant Diseases
:
  • Primary Immune Deficiency Disorders
  • Hemophagocytic Lymphohistiocytosis
  • Procedure: Allogeneic Bone Marrow Transplantation